alloxan has been researched along with tretinoin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
Lee, SW; Lee, YK; Moon, S; Um, SJ | 1 |
Delgadillo-Guzmán, D; García Garza, R; Hady, K; Marszalek, JE; Meléndez Valenzuela, A; Quintanar Escorza, MA; Ramírez-Moreno, A; Sharara-Núñez, I | 1 |
3 other study(ies) available for alloxan and tretinoin
Article | Year |
---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Suppressive role of OGT-mediated O-GlcNAcylation of BAP1 in retinoic acid signaling.
Topics: Alloxan; Cell Differentiation; Cells, Cultured; Glycosylation; Humans; N-Acetylglucosaminyltransferases; Signal Transduction; Structure-Activity Relationship; Tretinoin; Tumor Suppressor Proteins; Ubiquitin Thiolesterase | 2017 |
All-trans retinoic acid improves pancreatic cell proliferation on induced type 1 diabetic rats.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Glycemic Index; Pancreas; Rats; Rats, Wistar; Tretinoin; Vitamin E | 2020 |